Chong‐Jen Yu
Impact in
- Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Pleural and Pulmonary Diseases
Papers in
-
- Lung Cancer Treatments and Mutations 179
- Lung Cancer Diagnosis and Treatment 105
- Respiratory Support and Mechanisms 52
- Chronic Obstructive Pulmonary Disease (COPD) Research 46
- Co-authors
- Pan‐Chyr YangJin‐Yuan ShihJames Chih‐Hsin YangLi‐Na LeePo‐Ren HsuehYih‐Leong ChangJung‐Yien ChienJann‐Yuan Wang
- Journals
- Journal of Thoracic Oncology (31 papers)Annals of Oncology (23 papers)Lung Cancer (21 papers)PLoS ONE (21 papers)Journal of Clinical Oncology (19 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Chong‐Jen Yu
607 papers receiving 20.5k citations
Hit Papers
Peers
Comparison fields: 5 of 178
- Pulmonary and Respiratory Medicine 10.8k
- Critical Care and Intensive Care Medicine 1.7k
- Oncology 6.7k
- Infectious Diseases 3.8k
- Cancer Research 2.2k
Countries citing papers authored by Chong‐Jen Yu
This map shows the geographic impact of Chong‐Jen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong‐Jen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong‐Jen Yu more than expected).
Fields of papers citing papers by Chong‐Jen Yu
This network shows the impact of papers produced by Chong‐Jen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong‐Jen Yu. The network helps show where Chong‐Jen Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chong‐Jen Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 18 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 7 | |
| 7 | Prediction of Mandibular Advancement Device Response Using CPAP Pressure in Different Polysomnographic Phenotypes | 2022 | 2 |
| 8 | LINC00887 aggravates the malignant progression of glioma via upregulating CCND1 | 2021 | 6 |
| 9 | 2021 | 11 | |
| 10 | Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia Hit paper breakdown → | 2020 | 501 |
| 11 | 2019 | 13 | |
| 12 | 2019 | 24 | |
| 13 | 2018 | 20 | |
| 14 | Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy Hit paper breakdown → | 2015 | 367 |
| 15 | 2015 | 61 | |
| 16 | 2014 | 44 | |
| 17 | 2012 | 54 | |
| 18 | 2011 | 361 | |
| 19 | Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis. | 2010 | 40 |
| 20 | 1992 | 78 |
About Chong‐Jen Yu
Chong‐Jen Yu is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine, Infectious Diseases, Oncology and Epidemiology, having authored 629 papers that have together received 20.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (179 papers), Lung Cancer Diagnosis and Treatment (105 papers), Lung Cancer Research Studies (93 papers), Tuberculosis Research and Epidemiology (88 papers), Mycobacterium research and diagnosis (65 papers), Colorectal Cancer Treatments and Studies (55 papers), Respiratory Support and Mechanisms (52 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (46 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (10.8k citations), Critical Care and Intensive Care Medicine (1.7k citations), Oncology (6.7k citations), Infectious Diseases (3.8k citations) and Cancer Research (2.2k citations). Chong‐Jen Yu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Pan‐Chyr Yang, Jin‐Yuan Shih, James Chih‐Hsin Yang, Li‐Na Lee, Po‐Ren Hsueh, Yih‐Leong Chang, Jung‐Yien Chien, Jann‐Yuan Wang, Huey‐Dong Wu and Chao‐Chi Ho. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Lung Cancer, PLoS ONE and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.